Haldol and Lenalidomide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Haldol (haloperidol) and Lenalidomide (lenalidomide). Common drug interactions include hypocalcaemia among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Haldol and Lenalidomide. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Haldol?

Haldol has active ingredients of haloperidol. It is often used in schizophrenia. eHealthMe is studying from 23,102 Haldol users. Check the latest studies of Haldol.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.



On Jul, 19, 2026

40 people who take Haldol and Lenalidomide together, and have interactions are studied.

Haldol and Lenalidomide drug interactions.

What are the common drug interactions of Haldol and Lenalidomide, by gender? *:

female:

  1. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Nausea (feeling of having an urge to vomit)
  4. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  5. Oral pain
  6. Platelet count decreased
  7. Vomiting
  8. Back pain
  9. Dysphagia (a condition in which swallowing is difficult or painful)
  10. Fatigue (feeling of tiredness)

male:

  1. Pneumonia
  2. Renal failure (kidney dysfunction)
  3. Back pain
  4. Bone density decreased
  5. Bone pain
  6. Breast hyperplasia (accumulation of abnormal cells in a breast duct)
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Cardiac failure congestive
  9. Cardiomyopathy (weakening of the heart muscle)
  10. Carotid artery stenosis (narrowing of carotid artery)

What are the common drug interactions of Haldol and Lenalidomide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  2. Pseudomonal bacteraemia (p. aeruginosa cause of bacterial infections of the blood)

50-59:

  1. Paraganglion neoplasm (paraganglion tumour)
  2. Pneumonia
  3. Renal failure (kidney dysfunction)
  4. Acquired oesophageal web (structural abnormalities in the oesophagus)
  5. Acute myocardial infarction (acute heart attack)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anaemia (lack of blood)
  8. Anxiety
  9. Aortic arteriosclerosis (hardening of the aortic arteries)
  10. Aortic calcification (aortic calcification sign of heart valve disease)

60+:

  1. Anaemia (lack of blood)
  2. Back pain
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Fatigue (feeling of tiredness)
  5. Acquired oesophageal web (structural abnormalities in the oesophagus)
  6. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  7. Anxiety
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Asthma
  10. Autonomic neuropathy (malfunction of the autonomic nervous system (ans))

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 34 people, 85.00%
  2. Bone Pain: 10 people, 25.00%
  3. Restless Leg Syndrome (a powerful urge to move your legs): 10 people, 25.00%
  4. Chronic Kidney Disease: 10 people, 25.00%
  5. Secondary Immunodeficiency (lack of immunity due to some disease): 10 people, 25.00%
  6. Pain: 8 people, 20.00%
  7. Agitation (state of anxiety or nervous excitement): 8 people, 20.00%
  8. Constipation: 7 people, 17.50%
  9. High Blood Pressure: 7 people, 17.50%
  10. Stress And Anxiety: 5 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Haldol and Lenalidomide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Haldol and Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Haldol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Haldol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lenalidomide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on haloperidol and lenalidomide (the active ingredients of Haldol and Lenalidomide, respectively), and Haldol and Lenalidomide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: